|4Jan 31, 4:19 PM ET

Cearley Cassia 4

4 · Icosavax, Inc. · Filed Jan 31, 2023

Insider Transaction Report

Form 4
Period: 2023-01-30
Cearley Cassia
Chief Business Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-01-30$0.84/sh+25,102$21,086156,840 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-01-3025,1022,511 total
    Exercise: $0.84Exp: 2029-12-01Common Stock (25,102 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vested on 12/2/2020, and 1/48th of the shares subject to the option vest monthly thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION